Oh wow TH first up!!
Request for a trading halt
Actinogen Medical Limited ACN 086 778 476 (ASX: ACW) (the Company), requests that the Company's
securities be placed into trading halt with immediate effect.
Pursuant to ASX Listing Rule 17.1, the Company requests the trading halt pending an announcement of the
results of the XanaCIDD phase 2a clinical trial.
We anticipate that the trading halt will be required until the earlier of the release of the announcement or
no later than 10.00 am AEST on Monday, 12 August 2024.
Add to My Watchlist
What is My Watchlist?
